DRX9000 Spinal Decompression

[Axiom Worldwide has announce a new DRX9000 based upon the feedback and survey results from existing customers. The biggest change is the removal of the video monitoring system which many of the surveyed doctors said was under utilized since most of the patients being treated had fallen asleep. As a result of removing the monitoring system, the new DRX9000 cost has been reduced and the savings passed along to the doctors. For those DRX9000 doctors still wanting the video system, it will be offered as a option.]

Tampa, FL, June 3, 2009: Axiom Worldwide today announces the release of its NEW “DRX9000™ True Non-Surgical Spinal Decompression System.” The NEW DRX9000 is the result of feedback and survey results gathered from existing U.S. and international customers. The NEW DRX9000 offers new features and a new look with the same quality and clinical efficacy that the world has come to expect from Axiom products. One significant change has been the removal of the video monitor. In survey responses most doctors indicated that the majority of their patients fell asleep during the treatment. Therefore, the video feature was greatly under utilized. The removal of this feature has resulted in a cost savings that will be passed through to doctors purchasing the new device. For those customers that still demand video capability, the feature can be purchased as an option. To see Axiom’s NEW DRX9000 or to learn more about its many new features, please visit: www.AxiomWorldwide.com or call: (877) 438-0663 to speak with a representative about a SPECIAL INTRODUCTORY PRICE OFFER!

About Axiom Worldwide

Axiom manufactures medical devices that provide safe, non-surgical alternatives in the treatment of chronic back pain. Data published in Peer-Reviewed journals shows that patients treated on our DRX9000™ have had clinically significant and positive outcomes. As a result, our products are installed in over 20 countries around the world. For additional information on Axiom Worldwide, please visit www.AxiomWorldwide.com or contact Axiom Worldwide, 9423 Corporate Lake Drive, Tampa, FL 33634, telephone: (877) 438-0663.

[In a study of 50 patients, Dr. Noriaki Yamamoto and others reported that 76% of patients were satisfied with the treatment they received using the DRX9000. This study was not sponsored by Axiom Worldwide, the manufacturer of the DRX9000 spinal decompression system.]

Japanese study reports 76% of patients were satisfied after treatment on the DRX-9000!

Tampa, FL, April 30, 2009: A study titled, “The treatment of lumbar disc disease using DRX-9000” is published in the December issue of the Nigata University Journal of Health and Welfare. After treating fifty patients on the DRX-9000, Dr. Noriaki Yamamoto and others reported that 76% of patients were satisfied with the treatment. The patients received 30-minute sessions every week or 2 weeks, for 3 months and revealed a decrease in pain of 4.91 ± 0.93 to 2.69 ± 1.02 (p<0.01). Although the treatment program used by Dr. Yamamoto did not follow Axiom’s published protocol, positive results were still demonstrated. A previous study following Axiom’s protocol which was published in the December 2008 issue of the Journal of Medicine revealed a mean patient rating of 7.61 (0-10 scale) at the mid point of treatment and 8.1 after the final week of treatment. To review additional clinical studies please go to www.axiomworldwide.com/research.aspx.

The foregoing study was not sponsored by Axiom Worldwide. Axiom has made no determination of and makes no representations as to the design, scope or manner in which the study was conducted. Axiom Worldwide’s referencing the presentation of the study should not be construed to mean that Axiom Worldwide represents that the study establishes any conclusive success rate or the efficacy of the device. The information is offered simply to demonstrate the exciting activity ongoing with the DRX9000. As always, individual patient’s experiences with the DRX9000 may vary and patients should always consult with their physician to determine whether treatment on the DRX9000 makes sense for them.

Axiom Worldwide manufactures and distributes its flagship products, the DRX9000 True Non-surgical Spinal Decompression System™ and DRX9000C™ in medical markets around the globe. Axiom also manufactures a digital electroceutical device, the EPS8000™, for use in relieving pain and for use in muscular rehabilitation. Axiom prides itself on providing safe, non-surgical alternatives that patients should consider prior to undergoing surgery. For additional information please visit: www.AxiomWorldwide.com. To schedule an interview please contact: Amber Pacetti, Marketing at: telephone: 001-813-249-6444 or email: apacetti@axiomworldwide.com.

[Business Wire press release from Axiom Worldwide of Florida, makers of the popular DRX9000 and DRX9000C line of spinal decompression systems. Clinical data on the DRX9000 will be presented at the CONy in Greece.]

Clinical Data Utilizing the DRX9000(TM) Will Be Presented at the CONy in Athens, Greece!
Friday October 10, 5:13 pm ET

TAMPA, Fla.–(BUSINESS WIRE)–Clinical data utilizing the DRX9000 True Non-Surgical Spinal Decompression System™ will be presented at the 2nd World Congress on Controversies in Neurology (CONy) in Athens, Greece October 23-26, 2008. The first study, is an IRB-approved, prospective multi-center phase II, non-randomized pilot study authored by Dr. John Leslie of the Mayo Clinic and others. This study was designed to evaluate the effectiveness and safety of the DRX9000 in treating chronic LBP [lower back pain]. A greater than 50% reduction in pain score was observed after two weeks of treatment and upon completion of the entire six week protocol an amazing success rate of 88.9% was documented. Improvement of Oswestry scores and a decreased consumption of adjunctive pain medication were also noted. The second study, is retrospective data which included lumbar spine CT scans before and after patients were treated on the DRX9000 that demonstrates possible morphological changes associated with treatment. The authors conclude, “A significant reduction in chronic LBP after non-invasive spinal decompression correlated with an increase in disc height.” One of the authors of the studies will be presenting the data at the 2nd World Congress CONy. Abstracts of both studies will be available. These presentations represent an effort to further educate the International Community on the effectiveness of our products.

Non-treatment or control groups were not included making efficacy outcome versus placebo or spontaneous recovery difficult to determine. Randomized double-blinded or comparative long-term outcome trials are needed to further prove the efficacy of non-surgical spinal decompression systems such as the DRX9000™ for the routine treatment of chronic LBP. This study was partially funded by Axiom Worldwide.

A randomized controlled trial is needed to prove that restoration in disc height is the mechanism through which non-surgical spinal decompression systems such as the DRX9000™ leads to these impressive reductions in pain.

Axiom Worldwide manufactures and distributes its flagship products, the DRX9000 True Non-surgical Spinal Decompression System™, DRX9000C™, and DRX9500™ in medical markets around the globe. Axiom also manufactures a digital electroceutical device, the EPS8000™, for use in relieving pain and for use in muscular rehabilitation. Axiom prides itself on providing safe, non-surgical alternatives that patients should consider prior to undergoing surgery. For additional information please visit: www.AxiomWorldwide.com.

To schedule an interview please contact: Amber Pacetti, Marketing at: telephone: 001-813-249-6444 or email: apacetti@axiomworldwide.com.

Contact:

Axiom Worldwide, Tampa
Amber Pacetti, 813-249-6444

[Here's another press release from Axiom Worldwide. A special report supported by Axiom Worldwide on treating chronic lower back pain.]

TAMPA, Fla.–(BUSINESS WIRE)–In most industrialized countries, chronic low back pain is recognized as a widespread condition. However, a Special Report supported through a grant from Axiom Worldwide is now featured in the January issue of Pain Medicine News. The Special Report was first featured in the December 2007 issue of Anesthesiology News and was then presented on-line at: www.painmedicinenews.com in early January. The article has since become the most read article on this website. The Special Report highlights exciting research on a medical device that offers patients a non-surgical treatment option in treating chronic low back pain. The device is called the DRX9000™ and is manufactured by Axiom Worldwide of Tampa, FL. The authors of this Special Report are from the prestigious institutions of Duke University School of Medicine, Mayo Clinic, and Johns Hopkins University School of Medicine. They conclude their Special Report by stating, “The DRX9000™ computerized nonsurgical spinal decompression systems were designed to provide maximum patient benefits with the use of a noninvasive approach that may help minimize health care resources and offer a potentially optimal therapeutic approach to the treatment of LBP (low back pain).”

Axiom Worldwide manufactures and distributes its flagship products, the DRX9000 True Non-surgical Spinal Decompression System™, DRX9000C™, and DRX9500™ in medical markets around the globe. Axiom also manufactures a digital electroceutical device, the EPS8000™, for use in relieving pain and for use in muscular rehabilitation. Axiom prides itself on providing safe, non-surgical alternatives that patients should consider prior to undergoing surgery. For additional information or to receive a copy of the Special Report featured in Pain Medicine News please visit: www.AxiomWorldwide.com. To schedule an interview please contact: Gary Dixon, VP Sales and Marketing at: telephone: 001-813-249-6444 or email: gdixon@axiomworldwide.com.

Contact:
Axiom Worldwide, Tampa
Gary Dixon, 813-249-6444

[From Businesswire.com: In Las Vegas on February 7-9, 2008 Dr. John Leslie of The Mayo Clinic and others will be presenting the clinical results of a pilot study to examine the effectiveness and safety of the DRX9000 for treating chronic lower back pain.]

The clinical results of an IRB-approved prospective, multi-center phase II, non-randomized pilot study utilizing the DRX9000™ will be presented by two of its authors at the Parker Seminars Las Vegas February 7 – 9, 2008. The study, authored by Dr. John Leslie of The Mayo Clinic and others, was designed to evaluate the effectiveness and safety of the DRX9000 in the treatment of chronic lower back pain. Patients enrolled in the study had suffered an overall average of ten years of chronic back pain. After two weeks of treatment on the DRX9000 there was an average 50% reduction in pain scores and upon completion of the entire six week protocol an amazing success rate of 88.9% was documented. The investigators also noted an improvement in Oswestry Disability score.

A second study will also be presented in Las Vegas. This study titled, “Treatment of 94 Outpatients With Chronic Discogenic Low Back Pain with the DRX9000: A Retrospective Chart Review,” reports that patients with a mean pain duration of 535 weeks reported a mean verbal numerical pain intensity rating equal to 6.05 on a 0 to 10 scale prior to treatment with the DRX9000. This decreased to a statistically and clinically significant mean rating of 0.89 after the last treatment on the DRX9000. Patients also reported a decrease in analgesic use and improvement in activities of daily living. In addition, the authors were able to follow-up at a mean 31 weeks with 29 patients and reveal mean values of 83% improvement in back pain and satisfaction of 8.55 on a 10-point scale. None of these patients reported requiring surgery. The authors also acknowledge that there are other spinal decompression systems available commercially. However, they suggest that the design difference between these devices, “…may lead to differing physical responses to therapy, so studies of one type of apparatus should not readily be applied across all machines.” The study will be released in print in the March 2008 issue of Pain Practice. Copies of both poster presentations will be available.

Non-treatment or control groups were not included making efficacy outcome versus placebo or spontaneous recovery difficult to determine. Randomized double-blinded or comparative long-term outcome trials are needed to further prove the efficacy of non-surgical spinal decompression systems such as the DRX9000™ for the routine treatment of chronic LBP.

Axiom Worldwide manufactures and distributes its flagship products, the DRX9000 True Non-surgical Spinal Decompression System™, DRX9000C™, and DRX9500™ in medical markets around the globe. Axiom also manufactures a digital electroceutical device, the EPS8000™, for use in relieving pain and for use in muscular rehabilitation. Axiom prides itself on providing safe, non-surgical alternatives that patients should consider prior to undergoing surgery.

For additional information or to receive a copy of the data presented at Parker Seminars Las Vegas please visit: www.AxiomWorldwide.com. To schedule an interview please contact: Gary Dixon, VP Sales and Marketing at: telephone: 001-813-249-6444 or email: gdixon@axiomworldwide.com.

Axiom Worldwide Non Surgical Medical Equipment

One of the leaders in the field of non surgical medical equipment is Axiom Worldwide. Commonly known for its spinal decompression table the DRX 9000, Axiom has a range of non surgical equipment, including a machine for electrical stimulation therapy. Here is a brief look at their products.

The DRX 9000

This previously mentioned machine has been designed as a non-invasive, non-surgical treatment option for sufferers of chronic lower back pain. Using a method of spinal decompression, the table uses motors and rollers to manipulate the spinal column at precise locations, freeing up space between vertebrae and damaged spinal discs, giving them a chance to heal. The DRX9000 is reasonably popular among well established chiropractors and gives patients a real choice against other alternatives.

The DRX9000C

The DRX9000C is a unit designed to relieve neck or cervical pain and shoulder pains. This headrest unit attaches to the DRX9000, and aims to relieve the tension at the root of the Cervical or shoulder pain. The unit uses cutting-edge technology to constantly monitor the pressures and forces being applied to a patients cervical spinal area. This allows the machine to adjust the patients angle in turn providing pinpointed treatment to the patients affected discs.

The DRX9500

Unlike the DRX9000C, the DRX9500 is a standalone unit for treating patients with chronic cervical pain. The headrest unit on this machine is non detachable, but still provides the same pinpoint accuracy and adjustability as the DRX9000C. Using rollers and motors this machine applies cyclic forces to the affected area, aimed at reducing the build up of pressure between intravertabral discs that have been damaged or weakened.

Axioms products are not cheap, this unit included, but the innovative approach to providing treatment to the patients affected areas has made the DRX units extremely popular among members of the chiropractic profession.

EPS8000

This machine provides electrical stimulation therapy, and is suggested as an additional therapy for spinal decompression patients. The electrical stimulation therapy is said to reduce the patients pain perception, making it easier to manipulate the vertebrae during Decompression therapy. An electrical current is sent to a specific area, either a single muscle or small group of muscles, and the charge causes the muscle to contract. Inducing this contraction, either a gentle or forceful one depending on the current being used, encourages the muscle to strengthen itself, and promotes the supply of blood flow to the treated area, both of which will dramatically increase the rate of healing.

The EPS8000 uses a technology called DDS, or Direct Digital Synthesis, which enables it to produce higher resolution and smoother feeling currents to ensure maximum impact from treatments.

Axiom Worldwide is constantly researching and developing the techniques involved in non-surgical treatments. This is one of the reasons products like the DRX9000 and DRX9500 are being used by so many chiropractors, because they know when they buy products from Axiom, they are buying state of the art!

DRX900 News:

TAMPA, Fla.–(BUSINESS WIRE)–Axiom Worldwide has received numerous inquiries regarding professional golfer Frank Nobilo’s return to the PGA Tour. Mr. Nobilo left the tour in 2003 because of serious back problems. On October 9, 2007, the Associated Press reported that he was making a comeback and had registered for the PGA Tour’s qualifying school. The report also went on to state that Mr. Nobilo was expected to play in this year’s New Zealand Open. The inquiries to Axiom Worldwide are in response to Frank Nobilo’s video testimonial regarding his treatment on the DRX9000™; specifically the teaser that he may play professionally again one day.

The above press release came from the October 13th Business Wire. See this link for the full story:

https://axiomworldwide.com/PressReleaseDetails.aspx?id=32

• DRX9000 reviews can be found on a number of sites. One site that seems to get a lot of DRX9000 commentary from everyday people is http://www.heelspurs.com. Both good and bad comments.

  Go to the site and in the search tab type in either “DRX9000″ or “DRX9000 reviews” to get some feedback from actual users. Be sure to select the Message Boards and Database search option.
  
   

• This site also has a smaller forum with people — mostly negatively — discussing the DRX9000: http://www.rebuildyourback.com/. The site owner is not a big fan of the DRX9000 machine. The forum does have a few positive experiences from users, though.
  
   
• A very skeptical DRX9000 comment here:

  http://www.livescience.com.

   

• Another DRX9000 general forum here:

  http://www.healthboards.com/boards/search.php?searchid=3893581

  It’s also has a lot of forum messages on back pain, VAX-D, sciatic pain, disc pain, etc.
  
   

Here’s a DRX9000 article excerpt from last April 2007 that I found on the World Chiropractic Alliance site.

Board complaints target ads, not effectiveness of spinal decompression device
Axiom Worldwide, USA, has revised its advertising and marketing campaign in response to various issues raised in the spinal decompression industry. It has been reported that several state chiropractic boards have been investigating what they say are unfounded advertising claims made by doctors using the company’s DRX9000 device.

Axiom indicates it has taken steps to provide its doctors with advertising that avoids these issues to allow doctors to concentrate on treating their patients without having to get involved with the resolution of the issues raised regarding the older advertising.

While some of the marketing language may change, Axiom stands by its assertion that the DRX9000 spinal decompression system is an effective and valuable therapeutic device supported by numerous studies and real‑life clinical experiences.

Visit http://www.worldchiropracticalliance.org/tcj/2007/apr/c.htm for the full article.

Traditional Low Back Pain Treatment

Prior to the invention of the DRX9000 spinal decompression system, traditional low back pain treatment included:

• Using analgesics and other pain medication
• Basic rest
• Exercise
• Physical therapy
• Massage
• Using ice or heat and gradually resuming activity
• Chiropractic treatment
• Acupuncture
• Surgery

Physical therapy and / or regular exercise programs almost always include as part of the treatment stretching, strengthening, and cardio conditioning.